To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/
Please contact us at US.email@example.com or (224) 554-5499.
ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)
USBU COVID-19 Supply Statement
Supporting Our Communities During the COVID-19 Outbreak:
A Message from Ramona Sequeira
Supporting Our Healthcare Providers During COVID-19
Update on US Recall of Two Lots of VONVENDI® [von Willebrand factor (recombinant)]
SEE ALL NEWS AND RELEASES >
Copyright 2019 Takeda Pharmaceutical Company Limited. All rights reserved.Certified Top Employer
You are about to leave www.Takeda.com/en-us and be redirected to another Takeda domain.